secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K
Filed at:   2022-12-16T23:59:59+00:00
Accession:  0001104659-22-127875
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

First Wave BioPharma receives Nasdaq bid price deficiency notice; proposes reverse stock split
--------------------------------------------------------------------------------

- On Dec 14, 2022, Nasdaq notified FWBI it fails $1.00 bid price rule; not eligible for automatic 180-day compliance period due to two prior reverse splits exceeding 1-for-250 ratio.
- Company plans to regain compliance via reverse stock split (1:3 to 1:40), to be voted on at Jan 9, 2023 special meeting.
- On Nov 22, 2022, closed $2.5M private placement to address minimum stockholders' equity requirement; now believes equity exceeds $2.5M threshold.
- Engaged Alliance Advisors as proxy solicitor for the reverse split proposal; fees up to $80,000.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000110465922127875/0001104659-22-127875-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000110465922127875/tm2232903d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-127875

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer